Home › Huntington's Disease › North Carolina › Durham
Huntington's Disease clinical trials in Durham, NC
4 studies for Huntington's Disease are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pridopidine Phase 3 Study in Huntington's Disease
RecruitingPhase 3
- Duke University, Durham
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RecruitingPhase 3
- Duke University Health System, Durham
- University Of NC At Chapel Hill, Chapel Hill · 10 mi away
Retinal Imaging in Neurodegenerative Disease
RecruitingObservational studyHealthy volunteers welcome
- Duke University Medical Center, Durham
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
RecruitingObservational studyHealthy volunteers welcome
- Duke University, Durham
About Huntington's Disease
Huntington's disease (HD) is an inherited disease that causes nerve cells in the brain to waste away. It causes disability that gets worse over time.
More about Huntington's Disease on MedlinePlus
Huntington's Disease trials in other cities
- Houston, TX5 studies
- Washington, DC4 studies
- New York City, NY4 studies
- Baltimore, MD4 studies
- Boston, MA4 studies
- Columbus, OH4 studies
- Nashville, TN4 studies
- Denver, CO4 studies
- Rochester, NY4 studies
- Cleveland, OH3 studies
- Birmingham, AL3 studies
- Wichita, KS3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.